This is a non-binding exploratory MOU with no financial terms — unlikely to move the stock near-term. The key catalyst for TLX remains the PDUFA date of September 11, 2026 for TLX101-Px. Monitor for any subsequent definitive agreements or expansion announcements.
Price Chart
Executive Summary
Telix Pharmaceuticals and United Imaging signed an MOU to evaluate a strategic research collaboration integrating Telix's radiopharmaceuticals with United Imaging's scanner platforms, initially focusing on TLX101-Px (Pixclara) in the U.S. The collaboration is exploratory and non-binding, with no financial terms disclosed, and does not change Telix's near-term revenue or regulatory trajectory.
Key Facts
- MOU signed with United Imaging Healthcare North America to evaluate integrated theranostics workflows.
- Initial focus on TLX101-Px (Pixclara, Floretyrosine F 18) in the U.S., with potential expansion to other products and markets.
- TLX101-Px NDA accepted by FDA in April 2026, with PDUFA goal date of September 11, 2026.
- No financial terms, revenue commitments, or binding obligations disclosed.
- Collaboration includes scanning protocol optimization, workflow tools, and pilot programs.
Financial Impact
No financial terms disclosed; collaboration is exploratory and non-binding.
Risk Factors
- MOU is non-binding and may not lead to a definitive agreement.
- TLX101-Px has not received marketing authorization in any jurisdiction; FDA decision pending.
- No revenue or cost-sharing details provided; financial impact uncertain.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3304988 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 6-K | $12.83 $11.95 | ▼ −6.86% | ▼ −8.99% | $10.55 (−17.77%) |
Sep 14, 2026 18d ago | Press Release | $11.78 $11.31 | ▼ −3.99% | ▼ −4.10% | $10.55 (−10.44%) |
Sep 2, 2026 4w ago | 6-K | $11.45 $11.90 | ▲ +3.93% | ▲ +4.89% | $10.55 (−7.86%) |
Sep 1, 2026 4w ago | Press Release | $11.45 $11.90 | ▲ +3.93% | ▲ +4.89% | $10.55 (−7.86%) |
Aug 20, 2026 6w ago | 6-K | $12.42 $11.38 | ▼ −8.41% | ▼ −9.53% | $10.55 (−15.06%) |
Aug 20, 2026 6w ago | Press Release | $12.42 $11.38 | ▼ −8.41% | ▼ −9.53% | $10.55 (−15.06%) |
Jul 30, 2026 9w ago | Press Release | $9.89 $11.52 | ▲ +16.48% | ▲ +12.97% | $10.55 (+6.67%) |
Jul 21, 2026 10w ago | Press Release | $10.32 $10.10 | ▼ −2.13% | ▲ +0.27% | $10.55 (+2.23%) |
Jul 21, 2026 10w ago | 6-K | $10.92 $9.98 | ▼ −8.61% | ▼ −7.38% | $10.55 (−3.39%) |
Jul 20, 2026 10w ago | Press Release | $10.92 $9.98 | ▼ −8.61% | ▼ −7.38% | $10.55 (−3.39%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access